The global human microbiome market, valued at US$623.3M in 2023, is forecasted to grow at a 31.5% CAGR, reaching US$814.6M by 2024 and US$4,206.0M by 2030.
The global autologous stem cell & non-stem cell therapies market, valued at US$3.9B in 2023, is forecasted to grow at a 32.3% CAGR, reaching US$5.5B by 2024 and US$22.2B by 2029. The major factor ...
The bioprocess containers market size is projected to reach USD 9.6 billion by 2026, at a CAGR of 26.3%. The major players operating in this market are Sartorius Stedim Biotech (France), Thermo F ...
The global exosome diagnostics and therapeutics market, valued at US$33M in 2023, is forecasted to grow at a 81.2% CAGR, reaching US$59M by 2024 and US$6848M by 2032.
The global CAR T-cell Therapy market, valued at US$37.4B in 2023, is forecasted to grow at a 39.6% CAGR, reaching US$5.5B by 2024 and US$29.0B by 2029. The growth of this market due to the rise i ...
The global long-read sequencing market, valued at US$596M in 2023, is forecasted to grow at a 32.8% CAGR, reaching US$758M by 2024 and US$3,129M by 2029. The main forces behind the growth of this ...
The global biomarkers market, valued at US$54.8B in 2023, is forecasted to grow at a 10.2% CAGR, reaching US$57.7B by 2024 and US$93.8B by 2029. The major factors driving the growth of this marke ...
The global biomaterials market, valued at US$42.3B in 2023, is forecasted to grow at a 7.3% CAGR, reaching US$45.2B by 2024 and US$64.2B by 2029. This growth is driven by increased funding in reg ...
The global cancer immunotherapy market size is projected to grow at a CAGR of 14.0%. Market growth can be attributed to the increasing incidence of cancer, rising demand for therapies with minima ...
The global precision diagnostics and medicine market, valued at US$132.46B in 2023, is forecasted to grow at a 11.1% CAGR, reaching US$145.53B by 2024 and US$246.66B by 2029. Factors such as the ...
The global biotech industry market size is estimated to grow from USD 483.0 billion in 2024 to USD 546.0 billion by 2025, at a growth rate of ~13.0%. The industry will see expanded use of biologi ...
The global monoclonal antibody therapeutics market, valued at US$222.6B in 2023, is forecasted to grow at a 14.5% CAGR, reaching US$252.6B by 2024 and US$497.5B by 2029. Driving factors of the ma ...
Latent demand for you, for your prospective client, or your prospective partners